Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

102
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
102
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

160
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
160

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deucravacitinib in patients with inflammatory bowel disease: 12-week efficacy and safety results from 3 randomized phase 2 studies in Crohn's disease and ulcerative colitis.

Journal of Crohn's & colitis·2025
Same author

Global evolution of inflammatory bowel disease across epidemiologic stages.

Nature·2025
Same author

Efficacy and Safety of Mirikizumab in the Treatment of Moderately to Severely Active Ulcerative Colitis Regardless of Baseline Modified Mayo Score: Results From the Phase 3 LUCENT Trials.

Crohn's & colitis 360·2025
Same author

Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response.

Nature reviews. Gastroenterology & hepatology·2025
Same author

Association of bile acid diarrhea with symptoms and disease activity in Crohn's disease: post-hoc clinical trial analysis of serum 7a-hydroxy-4cholestern-3-one, C4, in patients with active Crohn's disease.

Journal of Crohn's & colitis·2025
Same author

Prevention and interception trials in inflammatory bowel disease: an international taskforce assessment on clinical trial design.

The lancet. Gastroenterology & hepatology·2025
Same journal

Duodenal Fluid Microbiome Diversity and Pancreatic Cyst Status Among Patients Undergoing Pancreatic Surveillance.

Gastro hep advances·2026
Same journal

A Compelling Mimic: Fish Mouth Major Papilla and Villous Biliary Mucosa on Cholangioscopy.

Gastro hep advances·2026
Same journal

Cribriform Constriction: An Exceedingly Rare Cause of Progressive Dysphagia.

Gastro hep advances·2026
Same journal

Implications of Liver Failure Cutoffs for Mortality Prediction in Hospitalized Cirrhosis Patients: A Multicentric Study.

Gastro hep advances·2026
Same journal

Direct Oral Anticoagulant Type and Dose in Atrial Fibrillation With Decompensated Cirrhosis: A Propensity-Matched Analysis.

Gastro hep advances·2026
Same journal

Parasitic Persistence: The Diagnostic Challenge of Strongyloidiasis in a Nonendemic Setting.

Gastro hep advances·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

31.7K

Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine Learning.

David T Rubin1, Klaus Gottlieb2, Jean-Frederic Colombel3

  • 1University of Chicago Medicine Inflammatory Bowel Disease Center, Gastroenterology, Chicago, Illinois.

Gastro Hep Advances
|August 12, 2024
PubMed
Summary
This summary is machine-generated.

This study introduces a machine learning model to predict endoscopic disease activity in ulcerative colitis, achieving high accuracy in differentiating inactive from active disease using endoscopic videos.

Keywords:
Artificial IntelligenceCentral ReadingDeep SupervisionInflammatory Bowel Disease

More Related Videos

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.3K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K

Related Experiment Videos

Last Updated: Jun 17, 2025

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

31.7K
Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.3K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.0K

Area of Science:

  • Gastroenterology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Endoscopic assessment is crucial for inflammatory bowel disease trials but suffers from observer variability.
  • Standardizing endoscopic evaluation is essential for reliable clinical trial outcomes.

Purpose of the Study:

  • To develop and evaluate a machine learning (ML) model for predicting endoscopic Mayo Score (eMS) in ulcerative colitis.
  • To assess the ML model's ability to differentiate between inactive and active endoscopic disease using video data.

Main Methods:

  • Utilized 793 full-length endoscopic videos from 249 ulcerative colitis patients in a clinical trial.
  • Developed a video annotation approach to extract mucosal features and eMS labels for ML model training.
  • Evaluated model performance on two independent test sets against human expert reads.

Main Results:

  • The ML model achieved an AUC of 89% and 84% accuracy in differentiating inactive vs. active disease on the full test set.
  • On the consensus test set, the model demonstrated higher performance with an AUC of 92% and 89% accuracy.
  • The model showed strong predictive values, with positive predictive values of 80% and 87%, and negative predictive values of 85% and 90%.

Conclusions:

  • A novel ML model accurately differentiates key levels of endoscopic disease activity in ulcerative colitis.
  • The model, trained on video annotations and mucosal features, shows high performance in real-world clinical trial data.
  • This approach offers a potential solution to reduce inter- and intraobserver variability in endoscopic assessments.